- Home
- Mutual Funds
- Quant Mutual Fund
- Quant Healthcare Fund Direct-idcw
Fund Overview of Quant Healthcare Fund Direct-idcw
-
₹372.5 CrAUM
-
₹17.59NAV
-
0.90%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Quant Healthcare Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 21.27% | NA | 6.12% |
| 6 Months | 12.36% | NA | 12.92% |
| 1 Year | 10.92% | 10.92% | 6.04% |
| 2 Years | 16.12% | 7.76% | 24.93% |
Asset Allocation
equities
95.05%debt instruments
5.59%Quant Healthcare Fund Direct-idcw is one Equity mutual fund offered by Quant Mutual Fund. Launched on 17 Jul 2023, the fund aims Capital appreciation over long term. Equity Investments in stocks of companies in the healthcare sector. It manages assets worth ₹372.5 crore as on Sun May 31, 2026. The expense ratio stands at 0.9%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Quant Healthcare Fund Direct-idcw
The portfolio allocation consists of 95.05% in equities, 5.59% in debt instruments.Managed by Ankit A Pande, it has delivered a return of 10.92% in the last year, a total return since inception of 21.22%.
Those exploring investment options frequently compare the best sip plan while they plan long-term investment portfolios.
Fund Details
|
|
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Quant Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Quant Healthcare Fund Regular-growth
|
₹372 | 3.71% | 20.78% | 11.46% | 9.15% | - |
|
Quant Healthcare Fund Direct-growth
|
₹372 | 3.86% | 21.27% | 12.36% | 10.92% | - |
|
Quant Healthcare Fund Regular-idcw
|
₹372 | 3.71% | 20.78% | 11.46% | 9.15% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹8,636 | ₹550.01 | 21.45% | 13.24% | 15.54% |
| Nippon India Pharma Fund Direct-growth |
₹8,636 | ₹617.71 | 22.54% | 14.26% | 16.57% |
| Nippon India Pharma Fund-idcw |
₹8,636 | ₹118.77 | 21.45% | 13.24% | 15.54% |
| Nippon India Pharma Fund Direct-idcw |
₹8,636 | ₹169.06 | 22.54% | 14.26% | 16.57% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,454 | ₹42.60 | 26.38% | 16.26% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | ₹46.25 | 27.46% | 17.29% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,454 | ₹24.85 | 26.38% | 16.26% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | ₹27.93 | 27.46% | 17.29% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | ₹480.57 | 23.83% | 16.38% | 13.80% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,566 | ₹555.48 | 25.12% | 17.61% | 15.05% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Repo | Unspecified | 24.76% | ₹92.23 Cr |
| Hfcl Ltd | Technology | 9.55% | ₹35.58 Cr |
| Torrent Pharmaceuticals Ltd. 30-jun-26 | Healthcare | 9.45% | ₹35.19 Cr |
| Divi's Laboratories Ltd. 30-jun-26 | Healthcare | 9.33% | ₹34.75 Cr |
| Zydus Wellness Ltd | Consumer Staples | 8.74% | ₹32.54 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 8.73% | ₹32.53 Cr |
| Anthem Biosciences Ltd. | Healthcare | 8.66% | ₹32.25 Cr |
| Sms Pharmaceuticals Ltd | Healthcare | 7.66% | ₹28.53 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 6.98% | ₹26.00 Cr |
| Pfizer Ltd | Healthcare | 5.92% | ₹22.05 Cr |
| Hdfc Life Insurance Company Ltd. 30-jun-26 | Financial | 5.39% | ₹20.09 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.95% | ₹18.43 Cr |
| Hdfc Life Insurance Co Ltd | Financial | 3.73% | ₹13.89 Cr |
| Strides Pharma Science Ltd | Healthcare | 2.63% | ₹9.78 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.93% | ₹7.18 Cr |
| Adani Green Energy Ltd. 30-jun-26 | Energy & Utilities | 1.42% | ₹5.28 Cr |
| Government Of India 37175 091 Days Tbill 04ju26 Fv Rs 100 | Financial | 0.80% | ₹3.00 Cr |
| Government Of India 37370 091 Days Tbill 16jl26 Fv Rs 100 | Financial | 0.80% | ₹2.98 Cr |
| Government Of India 37391 091 Days Tbill 23jl26 Fv Rs 100 | Financial | 0.80% | ₹2.98 Cr |
| Government Of India 37423 091 Days Tbill 06ag26 Fv Rs 100 | Financial | 0.80% | ₹2.97 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹555.48 | 25.12% | 17.61% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹385.93 | 25.12% | 17.61% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹46.25 | 27.46% | 17.29% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.93 | 27.46% | 17.29% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹48.53 | 25.84% | 16.40% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹29.23 | 25.84% | 16.40% | - |
| SBI Healthcare Opportunities Fund-growth |
₹480.57 | 23.83% | 16.38% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹302.73 | 23.83% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹42.60 | 26.38% | 16.26% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹24.85 | 26.38% | 16.26% | - |
growth is based on 5Y returns of the funds
Frequently Asked Questions
Quant Healthcare Fund Direct-idcw
What is the current AUM of Quant Healthcare Fund Direct-idcw?
As of Sun May 31, 2026, Quant Healthcare Fund Direct-idcw manages assets worth ₹372.5 crore
How has Quant Healthcare Fund Direct-idcw performed recently?
- 3 Months: 21.27%
- 6 Months: 12.36%
What is the long-term performance of Quant Healthcare Fund Direct-idcw?
- Since Inception: 21.22%
What is the portfolio composition of Quant Healthcare Fund Direct-idcw?
Equity: 95.05%, Debt: 5.59%, Others: -0.64%.
Who manages Quant Healthcare Fund Direct-idcw?
Quant Healthcare Fund Direct-idcw is managed by Ankit A Pande from Quant Mutual Fund.
What is the market-cap allocation of Quant Healthcare Fund Direct-idcw?
Large Cap: 5.37%, Mid Cap: 22.36%, Small Cap: 72.27%.
Which are the top companies Quant Healthcare Fund Direct-idcw has invested in?
- Repo – 24.76% of the fund's portfolio
- HFCL Ltd – 9.55% of the fund's portfolio
- Torrent Pharmaceuticals Ltd. 30-JUN-26 – 9.45% of the fund's portfolio
- Divi's Laboratories Ltd. 30-JUN-26 – 9.33% of the fund's portfolio
- Zydus Wellness Ltd – 8.74% of the fund's portfolio
Which are the major sectors Quant Healthcare Fund Direct-idcw focuses on?
- Healthcare – 66.22% of the fund's portfolio
- Unspecified – 24.76% of the fund's portfolio
- Financial – 12.32% of the fund's portfolio
- Technology – 9.55% of the fund's portfolio
- Consumer Staples – 8.74% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
